We are live on ! Find out more
LAB icon

Standard BioTools
LAB

100 hedge funds and large institutions have $229M invested in Standard BioTools in 2016 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 35 increasing their positions, 29 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

21% more repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 29

13% more call options, than puts

Call options by funds: $1.14M | Put options by funds: $1.01M

6% less funds holding

Funds holding: 106 → 100 (-6)

25% less capital invested

Capital invested by funds: $306M → $229M (-$77.2M)

26% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 23

Holders
100
Holders Change
-6
Holders Change %
-5.66%
% of All Funds
2.66%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
35
Reduced
29
Closed
23
Calls
$1.14M
Puts
$1.01M
Net Calls
+$133K
Net Calls Change
-$9.86M

Top Buyers

1
LCS
Levin Capital Strategies
New York
+$15.1M
2
RFC
Russell Frank Company
Washington
+$8.17M
3
Jennison Associates
Jennison Associates
New York
+$3.13M
4
Neuberger Berman Group
Neuberger Berman Group
New York
+$2.46M
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$2.43M

Top Sellers

1
SCM
Scopia Capital Management
New York
-$16.3M
2
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
-$6.62M
3
O
OrbiMed
New York
-$5.08M
4
Goldman Sachs
Goldman Sachs
New York
-$4.37M
5
HCMT
Highland Capital Management (Texas)
Texas
-$2.91M
Name Holding Trade Value Shares
Change 		Change in
Stake
State Board of Administration of Florida Retirement System
51
State Board of Administration of Florida Retirement System
Florida
$220K -$5.59K -775 -3%
New York State Common Retirement Fund
52
New York State Common Retirement Fund
New York
$212K – – –
Citigroup
53
Citigroup
New York
$192K +$107K +14,883 +168%
ClearBridge Investments
54
ClearBridge Investments
New York
$191K -$2.09K -290 -1%
T. Rowe Price Associates
55
T. Rowe Price Associates
Maryland
$186K – – –
EMG
56
Ellington Management Group
Connecticut
$171K +$153K +21,200 New
Manulife (Manufacturers Life Insurance)
57
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$166K +$6.26K +868 +4%
MLICM
58
Metropolitan Life Insurance Company (MetLife)
New York
$163K – – –
Goldman Sachs
59
Goldman Sachs
New York
$158K -$4.37M -606,616 -97%
NFA
60
Nationwide Fund Advisors
Ohio
$157K – – –
Marshall Wace
61
Marshall Wace
United Kingdom
$142K -$570K -79,079 -82%
KeyBank National Association
62
KeyBank National Association
Ohio
$137K – – –
AIG
63
American International Group
New York
$137K +$14 +2 +0%
TIM
64
Thompson Investment Management
Wisconsin
$131K – – –
Dimensional Fund Advisors
65
Dimensional Fund Advisors
Texas
$130K – – –
VOYA Investment Management
66
VOYA Investment Management
Georgia
$128K – – –
AQR Capital Management
67
AQR Capital Management
Connecticut
$128K +$114K +15,863 New
Wells Fargo
68
Wells Fargo
California
$127K +$19.5K +2,707 +21%
BA
69
BlackRock Advisors
Delaware
$106K +$6.58K +912 +7%
Citadel Advisors
70
Citadel Advisors
Florida
$103K -$1.86M -258,262 -95%
BCM
71
Bayesian Capital Management
New York
$97K +$6.49K +900 +8%
BG
72
BlackRock Group
United Kingdom
$96K +$27.6K +3,833 +47%
PPA
73
Parametric Portfolio Associates
Washington
$90K +$80.3K +11,131 New
CG
74
Cutler Group
California
$55K -$51.6K -7,156 -51%
Group One Trading
75
Group One Trading
Illinois
$40K +$35.6K +4,936 New
1 2
3
4 5

LAB Hedge Fund Activity: Q1 2016 in Review

100 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Standard BioTools (LAB) for Q1 2016, worth a combined $229M — down 25% from $306M a quarter earlier.

Sellers outnumbered buyers: 23 funds closed out of LAB and 17 opened new positions — a net loss of 6 holders — while 29 trimmed existing stakes and 35 added.

The largest buyer was Levin Capital Strategies, opening a new position worth an estimated $15.1M. The largest seller was Scopia Capital Management, exiting entirely with an estimated $16.3M sold.

  • 100 institutional investors held Standard BioTools (LAB) as of Q1 2016, down from 106 in Q4 2015.
  • Funds reported $229M of Standard BioTools stock for Q1 2016, down 25% quarter-over-quarter.
  • 17 funds opened new Standard BioTools positions in Q1 2016 and 23 closed out, a net change of -6 holders.
  • The largest Standard BioTools buyer in Q1 2016 was Levin Capital Strategies, an estimated $15.1M added.
  • The largest Standard BioTools seller in Q1 2016 was Scopia Capital Management, an estimated $16.3M sold.

Based on aggregated 13F filings for Q1 2016.